Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.7700
-0.0500 (-6.10%)
Jun 16, 2026, 1:52 PM EST
Cell Source Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 0 | 0.07 | 0.02 | 0.22 | 0.09 | 0.24 |
Cash & Short-Term Investments | 0 | 0.07 | 0.02 | 0.22 | 0.09 | 0.24 |
Cash Growth | 5291.30% | 236.13% | -90.03% | 139.18% | -61.47% | 765.77% |
Other Receivables | - | 0.05 | - | - | - | - |
Receivables | - | 0.05 | - | - | - | - |
Prepaid Expenses | 0.29 | 0.16 | 0.16 | 0.16 | 0.2 | 0.18 |
Other Current Assets | 0 | 0 | 0.01 | 0.02 | 0.02 | 0.03 |
Total Current Assets | 0.29 | 0.29 | 0.2 | 0.41 | 0.31 | 0.45 |
Other Long-Term Assets | - | - | - | - | - | 0 |
Total Assets | 0.29 | 0.29 | 0.2 | 0.41 | 0.31 | 0.45 |
Accounts Payable | 1.93 | 1.89 | 1.47 | 0.68 | 0.22 | 0.19 |
Accrued Expenses | 6.11 | 5.57 | 4.75 | 4.22 | 3.12 | 3.08 |
Short-Term Debt | 9.85 | 9.6 | 8.32 | 7 | 4.66 | 3.31 |
Current Portion of Long-Term Debt | 0.97 | 0.99 | 1.08 | 0.91 | 1.83 | 1.49 |
Other Current Liabilities | 1.57 | 0.78 | 0.19 | 0.24 | 0.3 | 0.32 |
Total Current Liabilities | 20.43 | 18.82 | 15.81 | 13.04 | 10.14 | 8.4 |
Total Liabilities | 20.43 | 18.82 | 15.81 | 13.04 | 10.14 | 8.4 |
Common Stock | 0.05 | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 |
Additional Paid-In Capital | 27.48 | 27.6 | 26.01 | 23.67 | 21.32 | 17.72 |
Retained Earnings | -47.66 | -46.18 | -41.67 | -36.35 | -31.18 | -25.71 |
Total Common Equity | -20.14 | -18.54 | -15.61 | -12.64 | -9.83 | -7.95 |
Shareholders' Equity | -20.14 | -18.54 | -15.61 | -12.63 | -9.83 | -7.95 |
Total Liabilities & Equity | 0.29 | 0.29 | 0.2 | 0.41 | 0.31 | 0.45 |
Total Debt | 10.82 | 10.58 | 9.4 | 7.9 | 6.5 | 4.81 |
Net Cash (Debt) | -10.81 | -10.51 | -9.37 | -7.68 | -6.4 | -4.56 |
Net Cash Per Share | -0.25 | -0.25 | -0.25 | -0.22 | -0.19 | -0.16 |
Filing Date Shares Outstanding | 67.95 | 67.95 | 41.02 | 38.16 | 34.44 | 32.66 |
Total Common Shares Outstanding | 45.04 | 45.04 | 39.83 | 36.08 | 34.36 | 32.54 |
Working Capital | -20.14 | -18.54 | -15.61 | -12.63 | -9.83 | -7.95 |
Book Value Per Share | -0.45 | -0.41 | -0.39 | -0.35 | -0.29 | -0.24 |
Tangible Book Value | -20.14 | -18.54 | -15.61 | -12.64 | -9.83 | -7.95 |
Tangible Book Value Per Share | -0.45 | -0.41 | -0.39 | -0.35 | -0.29 | -0.24 |